While sialylated carbohydrate antigen KL-6 (KL-6) is usually used as a biomarker to evaluate lung fibrosis and can predict severity in patients with COVID-19, there was no significant difference between PMV and non-PMV in our study [28]. Here, MUC1 is linked to COVID-19.